Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking
about
Mechanisms for the modulation of dopamine d(1) receptor signaling in striatal neuronsSimvastatin prevents dopaminergic neurodegeneration in experimental parkinsonian models: the association with anti-inflammatory responsesNeurogenetics and pharmacology of learning, motivation, and cognitionAbeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61NMDA Receptor Function During Senescence: Implication on Cognitive PerformanceModulation of the glutamatergic transmission by Dopamine: a focus on Parkinson, Huntington and Addiction diseasesDopaminergic modulation of striatal neurons, circuits, and assembliesRecent progress in understanding subtype specific regulation of NMDA receptors by G Protein Coupled Receptors (GPCRs)Segregation and crosstalk of D1 receptor-mediated activation of ERK in striatal medium spiny neurons upon acute administration of psychostimulantsInteraction of the apolipoprotein E receptors low density lipoprotein receptor-related protein and sorLA/LR11Extrasynaptic NMDA receptors couple preferentially to excitotoxicity via calpain-mediated cleavage of STEPActivation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortexPSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor traffickingCytosolic sulfotransferase 1A3 is induced by dopamine and protects neuronal cells from dopamine toxicity: role of D1 receptor-N-methyl-D-aspartate receptor couplingActivation of dopamine D1 receptors blocks phencyclidine-induced neurotoxicity by enhancing N-methyl-D-aspartate receptor-mediated synaptic strengthTargeting Dyrk1A with AAVshRNA attenuates motor alterations in TgDyrk1A, a mouse model of Down syndrome.Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse.Post- versus presynaptic plasticity in L-DOPA-induced dyskinesia.Susceptibility to Calcium Dysregulation during Brain Aging.Dopamine D1 receptor-mediated NMDA receptor insertion depends on Fyn but not Src kinase pathway in prefrontal cortical neurons.Inhibition of NR2B phosphorylation restores alterations in NMDA receptor expression and improves functional recovery following traumatic brain injury in miceAMPA receptor plasticity in the nucleus accumbens after repeated exposure to cocaine.Neuroprotective effect of lovastatin by inhibiting NMDA receptor1 in 6-hydroxydopamine treated PC12 cellsNR2B-NMDA receptor-mediated increases in intracellular Ca2+ concentration regulate the tyrosine phosphatase, STEP, and ERK MAP kinase signalingPost-translational modification biology of glutamate receptors and drug addictionDopaminergic modulation of corticostriatal responses in medium spiny projection neurons from direct and indirect pathways.Preweaning Mn exposure leads to prolonged astrocyte activation and lasting effects on the dopaminergic system in adult male ratsRegulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapsesMind bomb-2 is an E3 ligase that ubiquitinates the N-methyl-D-aspartate receptor NR2B subunit in a phosphorylation-dependent manner.The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.Dopaminergic modulation of synaptic transmission in cortex and striatumAdrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilinGhrelin regulates phasic dopamine and nucleus accumbens signaling evoked by food-predictive stimuli.Effects of protein kinase A inhibitor and activator on rewarding effects of SKF-82958 microinjected into nucleus accumbens shell of ad libitum fed and food-restricted rats.Intrastriatal dopamine D1 antagonism dampens neural plasticity in response to motor cortex lesion.Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease.Striatal-enriched protein-tyrosine phosphatase (STEP) regulates Pyk2 kinase activity.Dopaminergic and cholinergic regulation of Fyn tyrosine kinase phosphorylation in the rat striatum in vivo.Modulation of striatal projection systems by dopamine.Treatment with a clinically-relevant dose of methylphenidate alters NMDA receptor composition and synaptic plasticity in the juvenile rat prefrontal cortex.
P2860
Q21131062-0BE3A1EA-127F-414D-8B9F-49F7D1E58008Q21560808-AE038347-7995-41F3-AF6E-2C9CED6D3DCCQ24602643-8A57A794-27D4-4024-9321-3ED6B1822A4BQ24620404-572A5282-9871-428C-ADA3-6A1D779716CEQ26770902-7BCED617-FD9E-42E3-862D-1FE158ADAC28Q26830654-E1434600-0C32-4F09-93CD-75F07D2D1203Q26862387-A4E92457-17B3-435B-8C35-4866DF3C37DCQ27006067-4AC85320-0269-472C-A44D-30DC26BC838FQ28395155-A5BA070E-B3D9-4BAA-827B-F4D8DF267EB6Q28509728-B0E827ED-E9FE-4BA3-8C64-55EE97E63E1CQ28567752-A4B082D0-8989-44CF-8E4D-262E76F4F85BQ28574586-EB17EB87-F6BB-4068-A24A-5AF6C53C8FA7Q28582674-30F9BA5D-3818-46D4-9EE2-1E81453E0D50Q28910380-A4F365CB-F148-469B-887D-E89217E65688Q30488298-CF83E653-5DDF-434C-8CB3-B917BAA5E731Q30490193-B6690B91-B096-4C19-9ECD-77E012DD2391Q30496867-8F4E6517-A27C-48C1-A835-D94A3677A22DQ33255884-80B359BD-BF86-4FEB-9EC3-E1F5C723FE81Q33868432-217E0CF7-039E-48C2-B3C2-A5033DF9DBC8Q33986661-80952CEF-8619-4605-81C3-58BD17522081Q34160587-EB08376E-73FE-44D2-B48D-D4A04FA7759FQ34233602-99849626-BD43-4D39-84B1-505BC143E379Q34547840-7C63233F-10C7-4208-9D16-3D3D08CDF035Q34628621-16DAF87C-FDB9-41EF-8B9D-17C3FC4BE4F9Q34706306-CA8119B5-5F46-49F7-B594-35A9CE0DD4FAQ34758219-3F3BA1DE-2A1E-4DE8-8B30-6BFDD67A2EFBQ34762896-A3F6823D-661D-476B-A810-4EFFD1FE8D70Q34990075-99FFB775-F46B-4D85-8E7A-95292A6BCB8BQ35071725-B60ED407-9DCF-44BA-80E2-44C5786BC1C0Q35195234-F6FFBC2C-E1EA-435A-8E71-B6448DBBAA74Q35282100-88980E0F-B67C-44D3-90DB-A2DFF4607B99Q35722397-D2703556-E10B-47BE-987A-F9602C95DE88Q35732746-8BD2F956-BCBE-4B12-9EEF-245B8EB0B52EQ35848385-4C24AFC4-C8A2-47CF-AAEA-B953F9167ACEQ35955621-6FB1D5D9-0D90-475F-BF10-9DB769D10AA1Q36020776-96E2A46A-5952-404F-8C7B-F48F2F8932C6Q36033151-23D29779-6447-4678-A88E-D93C6D016027Q36304940-876E67AF-C622-4582-A1D8-C16E67487157Q36367283-B598DA84-7491-41F2-B203-A7279AA9ABEBQ36699036-DFAA4D19-2254-4907-961F-D15378C2BF16
P2860
Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking
description
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2006
@ast
im April 2006 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2006/04/26)
@sk
vědecký článek publikovaný v roce 2006
@cs
wetenschappelijk artikel (gepubliceerd op 2006/04/26)
@nl
наукова стаття, опублікована у квітні 2006
@uk
مقالة علمية (نشرت في 26-4-2006)
@ar
name
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@ast
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@en
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@nl
type
label
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@ast
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@en
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@nl
prefLabel
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@ast
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@en
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@nl
P2093
P921
P1476
Dopamine D1 activation potenti ...... -dependent subunit trafficking
@en
P2093
Anthone W Dunah
Bradley T Hyman
Robert Spoelgen
P304
P356
10.1523/JNEUROSCI.0792-06.2006
P407
P577
2006-04-01T00:00:00Z